|
|
|
|
|
CUSIP No. 03748R754 |
|
|
|
Page 11 of 17 Pages |
Item 3. Source or Amount of Funds or Other
Consideration.
Item 3 to the Schedule 13D is hereby amended and restated as
follows:
The source and amount of funds used by each of WI and WCCL to
purchase its Stock is Working Capital. As used herein, the term
“Working Capital” includes income from the business operations of
each entity plus sums borrowed from, among other sources, banks and
brokerage firm margin accounts, to operate such business in
general.
Item 4. Purpose of Transaction.
Item 4 to the Schedule 13D is hereby amended and restated as
follows:
Pursuant to a series of transactions ending on October 7,
2022, WI has purchased an aggregate of 7,857,295 shares of Stock
for an aggregate of $49,898,325 in cash. The shares of Stock were
acquired by WI for the purpose of investment.
Pursuant to a series of transactions ending on June 22, 2022,
WCCL has purchased an aggregate of 1,177,111 shares of Stock for an
aggregate of $7,007,883 in cash. The shares of Stock were acquired
by WCCL for the purpose of investment. Pursuant to a series of
transactions ending on November 3, 2022, WCCL has sold for an
aggregate of $2,038,792 in cash an aggregate of 226,661 shares of
Stock.
Subject to the foregoing, the Reporting Persons intend to continue
to evaluate the Issuer’s business, prospects and financial
condition, the market for the Stock, monetary and stock market
conditions and other further developments. As a part of such
evaluation, one or more of the Reporting Persons may participate in
meetings or hold discussions with the Issuer’s management, other
shareholders and other persons in which the Reporting Persons may
express their views with respect to potential changes in the
operations, assets, capital structure or ownership of the Issuer as
a means of enhancing shareholder value. Such expression of views
may relate to one or more of the transactions specified in clauses
(a) through (j) of Item 4 of this Schedule 13D.
Depending upon, among other things, the factors set forth above,
the Reporting Persons reserve the right to (i) dispose of all
or part of their investment in the Stock at any time,
(ii) acquire additional shares of Stock by tender offer, in
the open market, in private transactions or otherwise,
(iii) propose a merger or similar business combination with
the Issuer or its affiliates, (iv) seek control of the Issuer
by stock ownership or otherwise, or (v) take any other action
with respect to the Issuer.
Except as set forth in this Item 4, the Reporting Persons have no
present plans or proposals that relate to or that would result in
any of the following actions:
(a) The acquisition by any person of additional securities of the
Issuer, or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its
subsidiaries;
(c) A sale or transfer of a material amount of assets of the Issuer
or any of its subsidiaries;
(d) Any change in the present board of directors or management of
the Issuer, including any plans or proposals to change the number
or term of directors or to fill any existing vacancies on the
board;